Granulocyte colony-stimulating factor alone at 12 μg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients

被引:30
作者
Sevilla, J
González-Vicent, M
Madero, L
García-Sánchez, F
Díaz, M
机构
[1] Hosp Infantil Univ Nino Jesus, Madrid 28009, Spain
[2] Ctr Trasfus Comunidad Madrid, Madrid, Spain
关键词
G-CSF; priming; LVL; children; mobilization;
D O I
10.1038/sj.bmt.1703662
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In children, the optimal mobilization schedule for harvesting peripheral blood progenitor cells (PBPC) is an issue of continuous research. We have studied a schedule based on high and daily divided doses of G-CSF (12 mug/kg body weight twice daily) for 4 days for PBPC priming. Toxicity related to G-CSF was observed in 13 patients (23%), mainly mild bone pain and myalgia. The median CD34(+) cell number collected was 4.4 (0.4-35 x 10(6)/kg body weight), with 46 patients achieving 2 x 10(6)/kg body weight (83.6%) after a single large volume leukapheresis. In conclusion, this mobilization schedule allows safe and efficient collection of the minimum target CD34(+) cell dose in most pediatric patients by only one procedure.
引用
收藏
页码:417 / 420
页数:4
相关论文
共 50 条
[41]   High dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels [J].
Kanfer, EJ ;
McGuigan, D ;
Samson, D ;
Abboudi, Z ;
Abrahamson, G ;
Apperley, JF ;
Chilcott, S ;
Craddock, C ;
Davis, J ;
MacDonald, C ;
Macdonald, D ;
Olavarria, E ;
Philpott, N ;
Rustin, GJS ;
Seckl, MJ ;
Sekhar, M ;
Stern, S ;
Newlands, ES .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :928-932
[42]   Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor [J].
B. Nasilowska-Adamska ;
A. Perkowska-Ptasinska ;
A. Tomaszewska ;
A. Serwacka ;
B. Marianska .
International Journal of Hematology, 2010, 92 :765-768
[43]   Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft [J].
Tayebi, H ;
Lapierre, V ;
Saas, P ;
Lienard, A ;
Sutton, L ;
Milpied, N ;
Attal, M ;
Cahn, JY ;
Kuentz, M ;
Blaise, D ;
Hervé, P ;
Tiberghien, P ;
Robinet, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :698-700
[44]   Basal CD34+ cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor [J].
de la Rubia, J ;
Lorenzo, JI ;
Torrabadella, M ;
Marin, P ;
Insunza, A ;
Sanz, MA .
HAEMATOLOGICA, 2004, 89 (12) :1530-1532
[45]   Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer [J].
Burns, LJ ;
Weisdorf, DJ ;
DeFor, TE ;
Repka, TL ;
Ogle, KM ;
Hummer, C ;
Miller, JS .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) :96-103
[46]   Bone Marrow Harvest in Pediatric Sibling Donors: Role of Granulocyte Colony-Stimulating Factor Priming and CD34+ Cell Dose [J].
Furey, Aimee ;
Rastogi, Sonal ;
Prince, Remi ;
Jin, Zhezhen ;
Smilow, Elana ;
Briamonte, Courtney ;
Kahn, Justine M. ;
Tanhehco, Yvette ;
Patel, Nita ;
George, Diane ;
Garvin, James ;
Bhatia, Monica ;
Satwani, Prakash .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) :324-329
[47]   Granulocyte colony-stimulating factor suppresses autologous tumor killing activity of the peripheral blood lymphocytes in the patients with ovarian carcinoma [J].
Ohta, Y ;
Hayakawa, S ;
Karasaki-Suzuki, M ;
Sugita, K ;
Komine, S ;
Chishima, F ;
Hatta, Y ;
Horie, T ;
Seo, N ;
Sheikh, A ;
Nemoto, N ;
Yamamoto, T .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2004, 52 (01) :81-87
[48]   Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation [J].
Hussein, Ayad Ahmed ;
Sharma, Shanta ;
Al-Zaben, Abdulhadi ;
Frangoul, Haydar .
PEDIATRIC TRANSPLANTATION, 2014, 18 (06) :625-630
[49]   Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model [J].
Hartung, G ;
Zeis, M ;
Glass, B ;
Dreger, P ;
Steinmann, J ;
Schmitz, N ;
Uharek, L .
BONE MARROW TRANSPLANTATION, 2003, 32 (01) :49-56
[50]   Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model [J].
G Hartung ;
M Zeis ;
B Glass ;
P Dreger ;
J Steinmann ;
N Schmitz ;
L Uharek .
Bone Marrow Transplantation, 2003, 32 :49-56